- Home
- LOGI vs PEN Comparison
LOGI vs PEN Comparison
Compare LOGI & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOGI | PEN |
|---|---|---|
| Founded | 1981 | 2004 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.6B | 12.5B |
| IPO Year | 1997 | 2015 |
Fundamental Metrics
Financial Performance| Metric | LOGI | PEN |
|---|---|---|
| Price | $103.04 | $317.46 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 16 |
| Target Price | $106.75 | ★ $360.14 |
| AVG Volume (30 Days) | ★ 959.2K | 325.0K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.62% | N/A |
| EPS Growth | 16.22 | ★ 1155.56 |
| EPS | ★ 4.80 | 0.82 |
| Revenue | N/A | ★ $1,403,665,000.00 |
| Revenue This Year | $8.30 | $14.34 |
| Revenue Next Year | $2.68 | $13.71 |
| P/E Ratio | ★ $21.20 | $387.82 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $83.32 | $221.26 |
| 52 Week High | $129.66 | $362.41 |
Technical Indicators
Market Signals| Indicator | LOGI | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 51.66 | 46.60 |
| Support Level | $101.52 | $314.91 |
| Resistance Level | $110.47 | $320.71 |
| Average True Range (ATR) | 2.61 | 1.71 |
| MACD | 0.75 | 0.27 |
| Stochastic Oscillator | 85.30 | 48.96 |
Price Performance
Historical ComparisonAbout LOGI Logitech International S.A.
Logitech was founded in 1981 and is headquartered in Lausanne, Switzerland. The company specializes in designing and manufacturing computer peripherals such as mice, keyboards, webcams, conference room cameras, headsets, and music-related products like wireless speakers.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.